Pharmaceutical Industry Intensifies Focus on Women’s Heart Health with Personalised Therapies

Representational Image

The pharmaceutical industry is rapidly redefining its approach to cardiovascular care by prioritising women’s heart health. Instead of relying on a one-size-fits-all model, companies are now developing gender-specific, tailored therapies that address the unique biological and hormonal factors affecting women. Today, more than 100 leading women’s health companies and startups are actively working on innovative solutions. Notably, the rise of Femtech startups is accelerating the development of specialised diagnostics, treatments, and digital health platforms focused on women.

Expanding Drug Pipeline for Women’s Cardiovascular Health

According to a recent survey by Pharmaceutical Research and Manufacturers of America, the 2026 drug pipeline includes 48 new medicines targeting cardiovascular diseases in women. The study, which covered 144 companies, highlights the growing industry commitment to addressing long-overlooked gender disparities in cardiac care. The expansion reflects a broader shift toward precision medicine, where therapies are designed to improve outcomes based on patient-specific characteristics, including gender.

Rising Burden of Heart Disease Among Indian Women

Cardiovascular disease (CVD) has emerged as the leading cause of mortality among Indian women. However, awareness remains alarmingly low. Nearly 62% of women surveyed believe heart disease primarily affects men, which often delays preventive care and early diagnosis. Roopali Khanna, Department of Cardiology, Sanjay Gandhi Post Graduate Institute of Medical Sciences (SGPGIMS), Lucknow, warns that such misconceptions are dangerous. She emphasises that while heart disease affects both genders, it manifests differently in women—often with subtler symptoms that are easily overlooked.

Also Read |  Healthcare Allocation Declines Despite Rising Health Cess

Unique Risk Factors and Comorbidities

Recent findings from USV Pvt. Ltd. highlight additional risk factors that disproportionately affect women. Conditions such as polycystic ovary syndrome (PCOS), type 2 diabetes, and gestational diabetes significantly increase the lifetime risk of heart disease. Moreover, insulin resistance plays a central role in the development of multiple comorbidities, including hypertension, dyslipidemia, and rheumatoid arthritis. These interconnected conditions further amplify cardiovascular risk in women.

Biological and Hormonal Influences

Biology also plays a critical role in women’s heart health. Hormonal changes during menopause lead to a decline in estrogen levels, which previously offered protective effects for the heart. As a result, postmenopausal women face increased risks, including elevated blood pressure and abnormal lipid profiles. Additionally, South Asian women are more vulnerable to early-onset hypertension and first-time heart attacks, often occurring nearly a decade earlier than in Western populations.

Silent Symptoms and Delayed Diagnosis

Unlike the classic image of a heart attack, women often experience atypical symptoms. These may include:

Also Read |  Indian Cancer Centers Embrace Patient-Reported Outcomes to Evaluate Therapy Benefit-Risk Profiles

Persistent fatigue

Pain in the jaw, neck, or upper back

Nausea or a burning sensation mistaken for acidity

Shortness of breath during routine activities

Because these symptoms are less obvious, women frequently delay seeking medical care, which reduces survival rates during first-time heart attacks.

Socio-Cultural Barriers to Care

Beyond biological factors, socio-cultural dynamics significantly impact women’s health outcomes in India. Many women prioritise their families’ well-being over their own, leading to what experts describe as a “self-care deficit.” As a result, symptoms are often dismissed as minor issues like fatigue or indigestion. Recognising this gap, the pharmaceutical industry is now moving beyond drug development to create integrated ecosystems of care, including awareness campaigns, preventive screenings, and digital health tools.

Prevention: Small Changes, Big Impact

Encouragingly, experts estimate that nearly 80% of premature heart attacks and strokes are preventable. Adopting simple lifestyle changes can significantly reduce risk:

Maintain blood pressure below 120/80 mmHg

Monitor cholesterol and blood sugar levels annually

Also Read |  Study Reveals Tea Bags Release Billions of Microplastics, Highlighting Health Risks

Replace trans fats (vanaspati) with healthier oils like mustard or olive oil

Reduce intake of refined carbohydrates such as white rice and maida

Limit salt consumption

Engage in at least 30 minutes of daily physical activity

Prioritise mental well-being to manage stress and cortisol levels

A Call to Action for Women’s Heart Health

Experts urge women to take proactive steps toward their health. Listening to early warning signs and prioritising preventive care can save lives. As Prof. Khanna emphasises, women must break the cycle of silence and make a conscious commitment to their well-being. Regular screenings, an active lifestyle, and timely medical intervention are essential to combating the growing heart health crisis.

The pharmaceutical industry’s increasing focus on women’s heart health marks a pivotal shift in global healthcare. As reported by pharmabiz.com, by combining personalised therapies, advanced research, and preventive strategies, stakeholders are working to bridge long-standing gaps in care. However, meaningful progress will require not just innovation but also awareness, behavioural change, and stronger healthcare systems that empower women to put their heart health first.